Search results for "Cutaneous Melanoma"

showing 10 items of 36 documents

Malignant metastatic melanoma to the gallbladder: Report of a peculiar case

2020

Highlights • Melanoma is one of the most aggressive and one of the fastest growing types of cancer. The gallbladder envolvement from a metastatic cutaneous malignant melanoma is a highly uncommon finding, usually associated with diffuse metastatic disease and observed during autopsy. • We report a case of a 35-years old Caucasian woman with isolated metastasis of gallbladder form cutaneous primary malignant melanoma underwent to laparoscopic cholecystectomy. • Malignant cutaneous melanoma is a skin cancer characterized by the highest mortality. Isolated metastasis of gallbladder are barely described and mostly present in a widespread metastatic disease. Surgical treatment is indicated consi…

medicine.medical_specialtyGallbladder metastasisMalignant melanomaPerformance statusbusiness.industryGeneral surgeryGallbladdermedicine.medical_treatmentMelanomaCancerCase ReportAutopsymedicine.diseaseMetastasisLaparoscopic cholecystectomy03 medical and health sciences0302 clinical medicinemedicine.anatomical_structure030220 oncology & carcinogenesisCutaneous melanomamedicine030211 gastroenterology & hepatologySurgeryCholecystectomybusinessInternational Journal of Surgery Case Reports
researchProduct

Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets

2019

Uveal Melanoma (UM) represents the most common primary intraocular malignant tumor in adults. Although it originates from melanocytes as cutaneous melanoma, it shows significant clinical and biological differences with the latter, including high resistance to immune therapy. Indeed, UM can evade immune surveillance via multiple mechanisms, such as the expression of inhibitory checkpoints (e.g., PD-L1, CD47, CD200) and the production of IDO-1 and soluble FasL, among others. More in-depth understanding of these mechanisms will suggest potential targets for the design of novel and more effective management strategies for UM patients.

0301 basic medicineCancer Researchimmune-escapemedicine.medical_treatmentReviewlcsh:RC254-282Fas ligand03 medical and health sciences0302 clinical medicineImmune privilegemedicinebusiness.industryMelanomaCD47Effective managementImmunotherapyinhibitory checkpointimmune-privilegemedicine.diseaselcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensImmune surveillanceimmune-escape; immune-privilege; immunotherapy; inhibitory checkpoints; uveal melanomainhibitory checkpoints030104 developmental biologyOncology030220 oncology & carcinogenesisCutaneous melanomaCancer researchimmunotherapyuveal melanomabusiness
researchProduct

Clinicopathological analysis of 1571 cutaneous malignant melanomas in Valencia, Spain: factors related to tumour thickness.

2006

Epidemiological studies on cutaneous melanoma in Mediterranean countries are scarce. Our aim was to perform a descriptive analysis of melanoma cases diagnosed in Valencia, Spain, and to evaluate the relationship between Breslow thickness and some clinical features. A total of 1571 patients with histologically confirmed cutaneous malignant melanoma diagnosed at the two main referral melanoma centres were evaluated retrospectively. For each patient the following clinical and pathological characteristics were selected: age, gender, anatomic site, histogenetic type, Breslow thickness, presence of ulceration, the stage, and symptoms such as bleeding, changes in size and colour, altered sensation…

AdultMalemedicine.medical_specialtyPathologySkin NeoplasmsHemorrhageDermatologyLogistic regressionBreslow ThicknessSex FactorsEpidemiologymedicineHumansStage (cooking)PathologicalMelanomaAgedRetrospective StudiesAged 80 and overbusiness.industryFootMelanomaAge FactorsAnatomical pathologyGeneral MedicineMiddle Agedmedicine.diseaseHandDermatologyLogistic ModelsSpainLymphatic MetastasisCutaneous melanomaMultivariate AnalysisSensation DisordersFemalebusinessActa dermato-venereologica
researchProduct

Characterization of the Microenvironment in Positive and Negative Sentinel Lymph Nodes from Melanoma Patients

2015

Melanomas are aggressive skin tumors characterized by high metastatic potential. Our previous results indicate that Natural Killer (NK) cells may control growth of melanoma. The main defect of blood NK cells was a decreased expression of activating NCR1/NKp46 receptor and a positive correlation of NKp46 expression with disease outcome in stage IV melanoma patients was found. In addition, in stage III melanoma patients, we identified a new subset of mature NK cells in macro-metastatic Lymph nodes (LN). In the present studies, we evaluated the numbers of NK cells infiltrating primary cutaneous melanoma and analyzed immune cell subsets in a series of sentinel lymph nodes (SLN). First, we show …

AdultMalePathologymedicine.medical_specialtyCD34lcsh:MedicineCD8-Positive T-LymphocytesBiologyTumor MicroenvironmentmedicineHumansCytotoxic T celllcsh:ScienceMelanomaAgedNeoplasm StagingAged 80 and overTumor microenvironmentMultidisciplinarySentinel Lymph Node BiopsyMacrophagesMelanomalcsh:REndothelial CellsMiddle Agedmedicine.diseaseAntigens Differentiation3. Good healthKiller Cells NaturalGranzyme BCutaneous melanomalcsh:QFemaleLymphCD8Research ArticlePLOS ONE
researchProduct

Abstract 4239: Pterostilbene, a natural polyphenol, elicits full protection against ultraviolet B radiation-induced skin carcinogenesis: Preclinical …

2011

Abstract Solar radiation exposure is the chief cause of nonmelanoma (i e, basal cell and squamous cell) skin cancer, and it is also a prime factor in the etiology of cutaneous melanoma The cancer-causing effects of ultraviolet (UV) radiation on the skin are mainly produced by UV-B radiation in the 290- to 320-nm range, the same range that produces burning in human skin (erythema) UV-B exposure can damage DNA and be immunosuppressive Thus, and considering the alarming numbers of skin cancers being diagnosed around the world, it is increasingly evident the need of effective protection from UV radiation Resveratrol (trans-3,5,4′-trihydroxystilbene; RES) is a phytoalexin present in a wide varie…

Cancer ResearchPterostilbeneintegumentary systemErythemabusiness.industryCancerHuman skinResveratrolmedicine.disease_causemedicine.diseaseToxicologychemistry.chemical_compoundOncologychemistryCutaneous melanomaCancer researchmedicineSkin cancermedicine.symptomCarcinogenesisbusinessCancer Research
researchProduct

The density and type of MECA-79-positive high endothelial venules correlate with lymphocytic infiltration and tumour regression in primary cutaneous …

2013

Aims Tumour-infiltrating lymphocytes have prognostic value in malignant melanoma. High endothelial venules (HEVs) are specialized vessels present in lymph nodes and tertiary lymphoid organs. CCL19, CCL21 and CCR7 regulate lymphocyte migration through HEVs. The aim of our study was to correlate HEV density in cutaneous primary and metastatic malignant melanomas with clinicopathological parameters, and with CCL19, CCL21 and CCR7 mRNA expression. Methods and results High endothelial venule density was evaluated by immunohistochemistry with a specific antibody, MECA-79, and chemokine expression was evaluated by real-time PCR. MECA-79-positive vessels, covered by cuboidal (C-HEV) or flat (F-HEV)…

MaleReceptors CCR7Pathologymedicine.medical_specialtySkin NeoplasmsHistologyEndotheliumvirusesHigh endothelial venulesC-C chemokine receptor type 7BiologyPathology and Forensic MedicineLymphocytes Tumor-InfiltratingmedicineHumansRNA MessengerRNA NeoplasmMelanomaLymphatic VesselsRetrospective StudiesChemokine CCL21MelanomaMembrane Proteinsvirus diseasesGeneral MedicineMiddle AgedPrognosismedicine.diseaseImmunohistochemistrydigestive system diseasesLymphatic systemmedicine.anatomical_structureAntigens SurfaceCutaneous melanomaChemokine CCL19ImmunohistochemistryFemaleCCL21Histopathology
researchProduct

Clinical performance of the Nevisense system in cutaneous melanoma detection: an international, multicentre, prospective and blinded clinical trial o…

2014

Summary Background Even though progress has been made, the detection of melanoma still poses a challenge. In light of this situation, the Nevisense electrical impedance spectroscopy (EIS) system (SciBase AB, Stockholm, Sweden) was designed and shown to have the potential to be used as an adjunct diagnostic tool for melanoma detection. Objectives To assess the effectiveness and safety of the Nevisense system in the distinction of benign lesions of the skin from melanoma with electrical impedance spectroscopy. Methods This multicentre, prospective, and blinded clinical study was conducted at five American and 17 European investigational sites. All eligible skin lesions in the study were exami…

AdultMalemedicine.medical_specialtySkin NeoplasmsAdolescentMedizinDermoscopyDermatologySensitivity and SpecificityBreslow ThicknessYoung AdultPositive predicative valueBiopsymedicineElectric ImpedancePhotographyHumansddc:610Prospective StudiesProspective cohort studyMelanomaEarly Detection of CancerAgedAged 80 and overmedicine.diagnostic_testbusiness.industryMelanomaOriginal ArticlesMiddle Agedmedicine.diseaseDermatologySurgeryClinical trialCarcinoma Basal CellDielectric SpectroscopyCutaneous melanomaCarcinoma Squamous CellFemalePatient SafetySkin cancerbusinessThe British journal of dermatology
researchProduct

Protocolo de diagnóstico histológico para muestras de pacientes con melanoma cutáneo. Documento de consenso de la SEAP y la AEDV para el Registro Nac…

2021

This article describes a proposed protocol for the histologic diagnosis of cutaneous melanoma developed for the National Cutaneous Melanoma Registry managed by the Spanish Academy of Dermatology and Venereology (AEDV). Following a review of the literature, 36 variables relating to primary tumors, sentinel lymph nodes, and lymph node dissection were evaluated using the modified Delphi method by a panel of 8 specialists (including 7 pathologists). Consensus was reached on the 30 variables that should be included in all pathology reports for cutaneous melanoma and submitted to the Melanoma Registry. This list can also serve as a model to guide routine reporting in pathology departments.

medicine.medical_specialtyConsensusSkin NeoplasmsHistologyVenereologyDelphi TechniqueMetodo delphiDermatologyPathology and Forensic MedicineVenereologyDelphi techniquePathologyRegistrosHumansMedicineRegistriesMétodo DelphiMelanomaSocieties Medicalbusiness.industryPronósticoHistologíaPrognosisDermatologyReview Literature as TopicConsensoCutaneous melanomaLymph Node ExcisionSentinel Lymph NodebusinessActas Dermo-Sifiliográficas (English Edition)
researchProduct

Willingness to pay for a cure of low-risk melanoma patients in Germany

2018

Malignant melanoma is potentially life-threatening but in most cases curable if detected early. Willingness to pay (WTP) is a preference-based construct that reflects burden of disease by assessment of the monetary value for a hypothetical cure from disease. Since WTP (directly as total amount of money) has not been assessed so far in patients with low risk melanoma, it was interesting to gain insights in this patient population and then, in a second step, compare it directly with the WTP of their treating dermato-oncologists. WTP was assessed in 125 patients with low-risk melanoma and additionally in 105 treating physicians, asking for the one-time and continuous payments they would be wil…

MelanomasMaleSkin NeoplasmsMedical DoctorsEconomicsHealth Care ProvidersCancer TreatmentMedizinSocial Scienceslcsh:MedicineDisease030207 dermatology & venereal diseases0302 clinical medicineSociologyCost of IllnessMedizinische FakultätGermanySurveys and QuestionnairesMedicine and Health SciencesOdds RatioPublic and Occupational HealthMedical Personnellcsh:ScienceMelanomaMultidisciplinaryMelanomaPatient PreferenceMiddle AgedProfessionsOncology030220 oncology & carcinogenesisIncomeFemaleResearch ArticleAdult-Education03 medical and health sciencesHealth EconomicsBreast cancerWillingness to payDiagnostic MedicinePhysiciansPsoriasisCancer Detection and DiagnosismedicineHumansddc:610Educational AttainmentAgedNeoplasm StagingHealth economicsbusiness.industrylcsh:RCancers and Neoplasmsmedicine.diseaseHealth CareRosaceaPeople and PlacesCutaneous melanomaPopulation Groupingslcsh:QbusinessFinanceDemography
researchProduct

Indicaxanthin from Opuntia Ficus Indica (L. Mill) impairs melanoma cell proliferation, invasiveness, and tumor progression.

2018

Abstract Background: A strong, reciprocal crosstalk between inflammation and melanoma has rigorously been demonstrated in recent years, showing how crucial is a pro-inflammatory microenvironment to drive therapy resistance and metastasis. Purpose: We investigated on the effects of Indicaxanthin, a novel, anti-inflammatory and bioavailable phytochemical from Opuntia Ficus Indica fruits, against human melanoma both in vitro and in vivo. Study Design and Methods: The effects of indicaxanthin were evaluated against the proliferation of A375 human melanoma cell line and in a mice model of cutaneous melanoma. Cell proliferation was assessed by MTT assay, apoptosis by Annexin V-Fluorescein Isothio…

0301 basic medicine3003MaleSkin NeoplasmsPyridinesPyridinePhytochemicalsMelanoma ExperimentalPharmaceutical ScienceIndicaxanthinApoptosisBcl-2 B cell lymphoma gene-2 (Bcl-2)chemistry.chemical_compoundMice0302 clinical medicineOpuntia Ficus Indica (L.Mill)Settore BIO/10 - BiochimicaDrug DiscoveryCXCL1 chemokine (C-X-C motif) ligand 1MelanomaNF-κB nuclear factor kappa BMTT 3-[45-dimethyltiazol-2-yl]-25-diphenyl tetrazolium bromideMelanomaNF-kappa BOpuntiaComplementary and Alternative Medicine2708 DermatologyBetaxanthinsCXCL1030220 oncology & carcinogenesisMolecular MedicinePhC phytochemicalGrowth inhibitionIndicaxanthinHumanBiologyPhytochemicalNHEM normal human epidermal melanocyte03 medical and health sciencesc-FLIP FLICE-inhibitory proteinIn vivoCell Line TumormedicineAnimalsHumansNeoplasm InvasivenessSkin NeoplasmCell ProliferationNeoplasm InvasiveneInflammationPharmacologyCell growthAnimalDrug Discovery3003 Pharmaceutical ScienceApoptosimedicine.diseaseMice Inbred C57BL030104 developmental biologyComplementary and alternative medicinechemistryTumor progressionList of Abbrevations: AxV-FITC annexin V-fluorescein isothiocyanateBetaxanthinFruitCutaneous melanomaCancer researchPI propidium iodide PIPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct